ENTA
Enanta Pharmaceuticals Inc
Price:  
16.00 
USD
Volume:  
513,549.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ENTA EV/EBITDA

-795.0%
Upside

As of 2024-07-15, the EV/EBITDA ratio of Enanta Pharmaceuticals Inc (ENTA) is -2.08. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ENTA's latest enterprise value is 276.76 mil USD. ENTA's TTM EBITDA according to its financial statements is -132.83 mil USD. Dividing these 2 quantities gives us the above ENTA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 11.6x - 19.4x 15.7x
Forward P/E multiples 17.8x - 23.2x 20.7x
Fair Price (108.70) - (118.86) (111.21)
Upside -779.4% - -842.9% -795.0%
16.00 USD
Stock Price
(111.21) USD
Fair Price

ENTA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-07-12 -2.08
2024-07-11 -1.92
2024-07-10 -1.86
2024-07-09 -1.83
2024-07-08 -1.71
2024-07-05 -1.67
2024-07-03 -1.63
2024-07-02 -1.68
2024-07-01 -1.62
2024-06-28 -1.60
2024-06-27 -1.55
2024-06-26 -1.48
2024-06-25 -1.49
2024-06-24 -1.48
2024-06-21 -1.43
2024-06-20 -1.35
2024-06-18 -1.42
2024-06-17 -1.46
2024-06-14 -1.58
2024-06-13 -1.67
2024-06-12 -1.65
2024-06-11 -1.67
2024-06-10 -1.57
2024-06-07 -1.59
2024-06-06 -1.53
2024-06-05 -1.51
2024-06-04 -1.48
2024-06-03 -1.51
2024-05-31 -1.52
2024-05-30 -1.45
2024-05-29 -1.43
2024-05-28 -1.43
2024-05-24 -1.45
2024-05-23 -1.46
2024-05-22 -1.57
2024-05-21 -1.52
2024-05-20 -1.52
2024-05-17 -1.47
2024-05-16 -1.61
2024-05-15 -1.66
2024-05-14 -1.64
2024-05-13 -1.59
2024-05-10 -1.55
2024-05-09 -1.59
2024-05-08 -1.57
2024-05-07 -1.62
2024-05-06 -1.86
2024-05-03 -1.95
2024-05-02 -1.75
2024-05-01 -1.69